pentobarbital will lessen the extent or effect of isavuconazonium sulfate by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. pentobarbital will reduce the level or impact of larotrectinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. buprenorphine subdermal